Peptides & Peptide Hormones
Bremelanotide (PT-141)
Bremelanotide (PT-141) is classified here as melanocortin receptor agonist peptide. Evidence level: High for its approved indication; not a performance drug.
Tesamorelin
Tesamorelin is classified here as ghrh analogue. Evidence level: High for its approved HIV-associated lipodystrophy indication.
Melanotan II
Melanotan II is classified here as synthetic melanocortin peptide. Evidence level: Limited clinical research; substantial unregulated-market use.
CJC-1295
CJC-1295 is classified here as long-acting ghrh analogue. Evidence level: Limited human trials.
Somatropin (Human Growth Hormone)
Somatropin (Human Growth Hormone) is classified here as recombinant human peptide hormone. Evidence level: High for approved GH indications.
Ipamorelin
Ipamorelin is classified here as growth-hormone secretagogue / ghrelin-receptor agonist peptide. Evidence level: Limited human pharmacology studies.
IGF-1 / Mecasermin
IGF-1 / Mecasermin is classified here as peptide growth factor. Evidence level: High for selected approved endocrine indications; performance claims are a separate question.
GHRP-2 (Pralmorelin)
GHRP-2 (Pralmorelin) is classified here as growth-hormone-releasing peptide. Evidence level: Human endocrine/pharmacology studies exist.
Mechano Growth Factor (MGF / IGF-1Ec)
Mechano Growth Factor (MGF / IGF-1Ec) is classified here as igf-1 splice-variant concept / research peptide products. Evidence level: Mostly mechanistic and preclinical for marketed peptide products.
GHRP-6
GHRP-6 is classified here as growth-hormone-releasing peptide. Evidence level: Older human endocrine studies.